OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study
Huwen Wang, Yuchen Wei, C.T. Hung, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 10, pp. 1130-1140
Open Access | Times Cited: 13
Huwen Wang, Yuchen Wei, C.T. Hung, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 10, pp. 1130-1140
Open Access | Times Cited: 13
Showing 13 citing articles:
Long COVID: a clinical update
Trisha Greenhalgh, Manoj Sivan, Alice Perlowski, et al.
The Lancet (2024) Vol. 404, Iss. 10453, pp. 707-724
Closed Access | Times Cited: 52
Trisha Greenhalgh, Manoj Sivan, Alice Perlowski, et al.
The Lancet (2024) Vol. 404, Iss. 10453, pp. 707-724
Closed Access | Times Cited: 52
Targeting the SARS-CoV-2 reservoir in long COVID
Amy D. Proal, Soo Aleman, Morgane Bomsel, et al.
The Lancet Infectious Diseases (2025)
Closed Access
Amy D. Proal, Soo Aleman, Morgane Bomsel, et al.
The Lancet Infectious Diseases (2025)
Closed Access
Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID-19 outcomes among outpatients: a target trial emulation investigation
Yuchen Wei, Christopher Boyer, Katherine Min Jia, et al.
Emerging Microbes & Infections (2025)
Open Access
Yuchen Wei, Christopher Boyer, Katherine Min Jia, et al.
Emerging Microbes & Infections (2025)
Open Access
Risk of Post-Acute Sequelae of COVID-19 and Oral Antivirals in Adults Aged Over 60 years: A Nationwide Retrospective Cohort Study
Hye Jin Joo, Eunji Kim, Kyungmin Huh, et al.
International Journal of Infectious Diseases (2025), pp. 107850-107850
Open Access
Hye Jin Joo, Eunji Kim, Kyungmin Huh, et al.
International Journal of Infectious Diseases (2025), pp. 107850-107850
Open Access
Short- and long-term comparative effectiveness of nirmatrelvir/ritonavir and molnupiravir in asthma patients: a cohort study
Guozhang Lin, Yuchen Wei, Zihao Guo, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Guozhang Lin, Yuchen Wei, Zihao Guo, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Postacute Sequelae of COVID (PASC or Long COVID): An Evidenced-Based Approach
Daniel O. Griffin
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 9
Open Access | Times Cited: 2
Daniel O. Griffin
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 9
Open Access | Times Cited: 2
COVID-19 vaccination modified the effect of nirmatrelvir–ritonavir on post-acute mortality and rehospitalization: a retrospective cohort study
Huwen Wang, Yuchen Wei, Guozhang Lin, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Huwen Wang, Yuchen Wei, Guozhang Lin, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality among patients who are immunocompromised with COVID-19 in Hong Kong: a retrospective cohort study
Guozhang Lin, Yuchen Wei, Huwen Wang, et al.
The Lancet Rheumatology (2024)
Closed Access | Times Cited: 1
Guozhang Lin, Yuchen Wei, Huwen Wang, et al.
The Lancet Rheumatology (2024)
Closed Access | Times Cited: 1
Long COVID across SARS‐CoV‐2 variants: Clinical features, pathogenesis, and future directions
Laurence S. C. Lok, Shuvam Sarkar, Chi‐Ming Lam, et al.
MedComm – Future Medicine (2024) Vol. 3, Iss. 4
Closed Access | Times Cited: 1
Laurence S. C. Lok, Shuvam Sarkar, Chi‐Ming Lam, et al.
MedComm – Future Medicine (2024) Vol. 3, Iss. 4
Closed Access | Times Cited: 1
Oral antivirals for acute symptoms and post-acute sequelae in SARS-CoV-2 infection
Vincent Soriano, Víctor Moreno‐Torres
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 10, pp. 1066-1067
Closed Access
Vincent Soriano, Víctor Moreno‐Torres
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 10, pp. 1066-1067
Closed Access
Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms?
César Fernández‐de‐las‐Peñas, Anabel Franco‐Moreno, María Ruiz‐Ruigómez, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 947-947
Open Access
César Fernández‐de‐las‐Peñas, Anabel Franco‐Moreno, María Ruiz‐Ruigómez, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 947-947
Open Access
Clinical Benefits of Sustained Oral Nirmatrelvir/Ritonavir Use for the Outpatient Treatment of COVID-19: Findings from the Taiwanese Health Authority Perspective Using a Decision Tree Modeling Approach
Matthew Sussman, Jennifer Benner, Tendai Mugwagwa, et al.
Journal of Market Access & Health Policy (2024) Vol. 12, Iss. 4, pp. 326-341
Open Access
Matthew Sussman, Jennifer Benner, Tendai Mugwagwa, et al.
Journal of Market Access & Health Policy (2024) Vol. 12, Iss. 4, pp. 326-341
Open Access
Gut microbiota in post-acute COVID-19 syndrome: not the end of the story
Yaping An, Linlin He, Xin Xu, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
Yaping An, Linlin He, Xin Xu, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
